BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33862200)

  • 1. Structural basis for the regulation of inducible nitric oxide synthase by the SPRY domain-containing SOCS box protein SPSB2, an E3 ubiquitin ligase.
    Li K; You T; Zhao P; Luo Y; Zhang D; Wei H; Wang Y; Yang J; Guan X; Kuang Z
    Nitric Oxide; 2021 Sep; 113-114():1-6. PubMed ID: 33862200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the SPRY domain of human SPSB2 in the apo state.
    Luo Y; Li K; Yang J; Zhang D; Zhou Y; Kuang Z
    Acta Crystallogr F Struct Biol Commun; 2019 Jun; 75(Pt 6):412-418. PubMed ID: 31204687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.
    Kuang Z; Lewis RS; Curtis JM; Zhan Y; Saunders BM; Babon JJ; Kolesnik TB; Low A; Masters SL; Willson TA; Kedzierski L; Yao S; Handman E; Norton RS; Nicholson SE
    J Cell Biol; 2010 Jul; 190(1):129-41. PubMed ID: 20603330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Characterization of Cyclic Peptidomimetics of the Inducible Nitric Oxide Synthase Binding Epitope That Disrupt the Protein-Protein Interaction Involving SPRY Domain-Containing Suppressor of Cytokine Signaling Box Protein (SPSB) 2 and Inducible Nitric Oxide Synthase.
    Harjani JR; Yap BK; Leung EW; Lucke A; Nicholson SE; Scanlon MJ; Chalmers DK; Thompson PE; Norton RS; Baell JB
    J Med Chem; 2016 Jun; 59(12):5799-809. PubMed ID: 27214043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of SPSB2 in complex with a rational designed RGD-containing cyclic peptide inhibitor of SPSB2-iNOS interaction.
    You T; Wang Y; Li K; Zhang D; Wei H; Luo Y; Li H; Lu Y; Su X; Kuang Z
    Biochem Biophys Res Commun; 2017 Jul; 489(3):346-352. PubMed ID: 28549582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of inducible nitric-oxide synthase by the SPRY domain- and SOCS box-containing proteins.
    Nishiya T; Matsumoto K; Maekawa S; Kajita E; Horinouchi T; Fujimuro M; Ogasawara K; Uehara T; Miwa S
    J Biol Chem; 2011 Mar; 286(11):9009-19. PubMed ID: 21199876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp90 inhibition renders iNOS aggregation and the clearance of iNOS aggregates by proteasomes requires SPSB2.
    Wang T; Luo S; Qin H; Xia Y
    Free Radic Biol Med; 2018 Mar; 117():90-98. PubMed ID: 29367003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox-stable cyclic peptide inhibitors of the SPSB2-iNOS interaction.
    Yap BK; Harjani JR; Leung EW; Nicholson SE; Scanlon MJ; Chalmers DK; Thompson PE; Baell JB; Norton RS
    FEBS Lett; 2016 Mar; 590(6):696-704. PubMed ID: 26921848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 19F NMR as a probe of ligand interactions with the iNOS binding site of SPRY domain-containing SOCS box protein 2.
    Leung EW; Yagi H; Harjani JR; Mulcair MD; Scanlon MJ; Baell JB; Norton RS
    Chem Biol Drug Des; 2014 Nov; 84(5):616-25. PubMed ID: 24813479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cyclic Peptide Inhibitor of the iNOS-SPSB Protein-Protein Interaction as a Potential Anti-Infective Agent.
    Sadek MM; Barlow N; Leung EWW; Williams-Noonan BJ; Yap BK; Shariff FM; Caradoc-Davies TT; Nicholson SE; Chalmers DK; Thompson PE; Law RHP; Norton RS
    ACS Chem Biol; 2018 Oct; 13(10):2930-2938. PubMed ID: 30226743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR regulation of SPSB1 controls inducible nitric oxide synthase induction.
    Lewis RS; Kolesnik TB; Kuang Z; D'Cruz AA; Blewitt ME; Masters SL; Low A; Willson T; Norton RS; Nicholson SE
    J Immunol; 2011 Oct; 187(7):3798-805. PubMed ID: 21876038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced nitric oxide production by macrophages treated with a cell-penetrating peptide conjugate.
    Rahman A; Matthews MA; Nowell CJ; Chalmers DK; Thompson PE; Nicholson SE; Barlow N; Norton RS
    Bioorg Chem; 2022 Jun; 123():105763. PubMed ID: 35366581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Infective Peptides to Enhance the Host Innate Response: Design, Development and Delivery.
    Norton RS
    Protein Pept Lett; 2018; 25(12):1101-1107. PubMed ID: 30381058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent cyclic peptide targeting SPSB2 protein as a potential anti-infective agent.
    Yap BK; Leung EW; Yagi H; Galea CA; Chhabra S; Chalmers DK; Nicholson SE; Thompson PE; Norton RS
    J Med Chem; 2014 Aug; 57(16):7006-15. PubMed ID: 25068993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for Par-4 recognition by the SPRY domain- and SOCS box-containing proteins SPSB1, SPSB2, and SPSB4.
    Filippakopoulos P; Low A; Sharpe TD; Uppenberg J; Yao S; Kuang Z; Savitsky P; Lewis RS; Nicholson SE; Norton RS; Bullock AN
    J Mol Biol; 2010 Aug; 401(3):389-402. PubMed ID: 20561531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ECS(SPSB) E3 ubiquitin ligase is the master regulator of the lifetime of inducible nitric-oxide synthase.
    Matsumoto K; Nishiya T; Maekawa S; Horinouchi T; Ogasawara K; Uehara T; Miwa S
    Biochem Biophys Res Commun; 2011 May; 409(1):46-51. PubMed ID: 21549100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPSB2 inhibits hepatitis C virus replication by targeting NS5A for ubiquitination and degradation.
    Wang M; Wang Y; Liu Y; Wang H; Xin X; Li J; Hao Y; Han L; Yu F; Zheng C; Shen C
    PLoS One; 2019; 14(7):e0219989. PubMed ID: 31344133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E3 ubiquitin ligase NKLAM positively regulates macrophage inducible nitric oxide synthase expression.
    Lawrence DW; Gullickson G; Kornbluth J
    Immunobiology; 2015 Jan; 220(1):83-92. PubMed ID: 25182373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments.
    Guéret SM; Thavam S; Carbajo RJ; Potowski M; Larsson N; Dahl G; Dellsén A; Grossmann TN; Plowright AT; Valeur E; Lemurell M; Waldmann H
    J Am Chem Soc; 2020 Mar; 142(10):4904-4915. PubMed ID: 32058716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the cellular toxicity of peptide inhibitors of intracellular protein-protein interactions by microinjection.
    Babu Reddiar S; Al-Wassiti H; Pouton CW; Nowell CJ; Matthews MA; Rahman A; Barlow N; Norton RS
    Bioorg Med Chem; 2021 Jan; 29():115906. PubMed ID: 33310547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.